We are registered as an independent intermediary for medicines with the Dutch Ministry of Health
This product, although approved, is not yet available to purchase via
TheSocialMedwork. However, if you are interested in staying informed
please leave your email address, and we will update you as soon as we
are able to source it and offer it for purchase.
Yes! I want to stay informed of developments with copanlisib.
Please leave your email address and we will inform you as soon as it's available to patients.
Relapsed Follicular Lymphoma
Mode of Action
Kinase inhibitor (targeted therapy)
FDA approved (USA)
Other medicines for blood cancer
If you are interested in other medicines for blood cancer, please visit our blood cancer page.
What is copanlisib?
(copanlisib) is a kinase inhibitor approved by the FDA on September 14,
2017, for the treatment of adults with relapsed follicular lymphoma who
have received at least two prior treatments known as systemic therapies
Follicular lymphoma is the most common slow-growing form of Non-Hodgkin
Lymphoma (NHL), accounting for approximately 12 % of all B-cell NHLs .
inhibits several key cell-signaling pathways and has been shown to
induce tumour cell death and inhibit their proliferation .
When will cobanlisib be available?
(copanlisib) was approved by the FDA on September 14, 2017 . We have
already contacted our sourcing partners and we will offer this product
on our website as soon as we are able to source it for our patients.
Buyer For EU individuals, VAT is 6% on medicines + 21% on shipping
Shipping Cost Estimate per order
VAT Tax can be claimed back by non-EU citizens on exiting the EU
Send this price estimate to your email address
Please complete the form, then try sending again.
*Once you provide us with the exact shipping address, the actual price may vary. After receiving the estimate, we may contact you to offer further assistance.
The more expensive medicines are patent-protected, and their prices are set by the pharmaceutical industry. We are constantly negotiating to get you best prices. As a social enterprise we only charge small fees to cover our operational costs.
Ordering with TheSocialMedwork is a safe and legal way to import a prescription medicine that has been approved in another country, but is not yet available where you live.
If you think that this medicine may be suitable for treating your condition, get in touch.
We'll answer any questions you might have and provide you with further information. Select the
Calculate Price tab to get a close estimate of the full cost of the medicine including delivery.
If you would like us to provide you with a precise quote we'll need to know the exact address of where you want us to send your medicine to.
2. Chat with your doctor
About whether this treatment might be suitable for you. In order to place an order with us, you’ll need to provide us with a prescription from your doctor who must be based in the same country where the medicine will be shipped to.
3. Place your order
Once you have your doctor's prescription you’re ready to place an order with us. Payment can be made by credit card, electronic bank transfer or Paypal.
As soon as we receive your payment we’ll process your order and your medicine will be shipped to you via a pharmacy.
Delivery time can vary from country to country but usually takes 1 to 3 weeks.
We'll send you a tracking number and keep you up to date on the status of your order.
Rest assured that we'll guide you through the entire process.
We'll let you know exactly what regulations need to be followed and the specific documentation you'll need to import the medicine into your country so that you get your treatment as quickly as possible. Ask us a question
What are the benefits shown in studies?
The efficacy of
Aliqopa (copanlisib) was evaluated in a single-arm phase 2 clinical
trial (CHRONOS-1) which involved 142 subjects following at least 2 prior
the study 59 % (95 % CI: 49, 68) of patients taking Aliqopa (copanlisib) responded to the treatment experiencing complete (14 %) or
partial (44 %) shrinkage of their tumors . The response lasted for a
median 12.2 months (range 0+, 22.6). The median time to response was
1.7 months (range 1.3 to 9.7 months) . Most common adverse
reactions (incidence ≥ 20 %) are hyperglycemia, diarrhea, decreased
general strength and energy, hypertension, leukopenia, neutropenia,
nausea, lower respiratory tract infections, thrombocytopenia .
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Medicine information contained herein may be time sensitive. The absence of a warning for a given medicine or combination thereof in no way should be construed to indicate that the medicine or combination is safe, effective or appropriate for any given patient. Always consult your treating physician before starting a course of treatment.
We've received requests for support from patients and doctors in over 120 countries, and delivered medicines to 6 continents.
They've given us a 5 star rating for our service. Read what our friends from around the world are saying...
"My experience has been excellent. TheSocialMedwork were totally knowledgeable about the medicine I was looking for, and how to get it delivered to me quickly and easily. I UNCONDITIONALLY recommend TSM to anyone, it is truly a world-class organisation."
— Charles, USA
"During the transaction process I was very well informed by TheSocialMedwork team. They have put so much effort to ensure the best service was offered to me. Moreover the medicine I ordered was imported two weeks earlier. I highly recommend TheSocialMedwork."
— Tomasz, Poland
"I hope you know how needed you are and what it means to get a prompt, succinct and helpful reply. You are our hero. You have given us realistic hope in obtaining needed drugs in a timely way."
— Regina, US
"TheSocialMedwork were so helpful in getting the right medication to me, expediting its delivery, and keeping in touch. They simply can't do enough to help you. I would not hesitate to recommend TheSocialMedwork to anybody. Lovely people."
— Stephen, UK
"Totally awesome! Keep up the great work you're doing!"
— Dee, Australia
"When the doctor tells you that there are no treatments left to try, search further - there may be new treatments in other countries."
— Charlotte, The Netherlands
"TheSocialMedwork's professional capabilities, kindness and patience deserve our gratitude and respect."
— Haoyu, China
"My daughter died at the age of 21 because she couldn't get the treatment that might have saved her life. Now TheSocialMedwork might be able to help people like Abigail to get the best treatment."
— Frank, Virginia, USA
"The team is highly professional, friendly and will take care of everything. More options for doctor and patients. This service is transparent, unique and necessary. Keep it up!"
— Pa Tric, Germany
"Excellent communication and clarifications given every time when requested. They also provide fantastic support and updates from the start till the end of the process of the medicine provisioning."
— Milos, Serbia & Montenegro
Registered with the Dutch Ministry of Health as an independent intermediary, Registration number 6730 BEM
Registered as a USA Delaware LLC.
DISCLAIMER: The Services of TheSocialMedwork do not replace a physician-patient relationship and are not intended as medical advice. TheSocialMedwork provides patients and physicians with existing treatment options abroad and creates access to these options after the patient and physician have made a professional decision.
Terms and Conditions